Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Clinical trial NCT04408820 · COMPLETED
Trial details
- NCT number
- NCT04408820
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-01
- Primary completion
- 2025-06-23
- Enrollment
- 2104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.